http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2200537-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e83d93ed02bbd6159e99b5a7796e3686
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-10
filingDate 1997-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a41709b4423e9f731c33f53928e5966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff92691387490cd791621ad338ba765
publicationDate 1997-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2200537-A1
titleOfInvention Process for the preparation of a benzothiazepine
abstract Process for the preparation of a 1,5-benzothiazepine derivative, or a salt thereof, of formula 1 where R1 represents H, an alkyl group or an alkoxy group and R2 represents H or a halogen, in which process a propanoic acid derivative of formula 2 where R1 and R2 are as defined above and R3 represents H or an alkyl group is subjected to an intramolecular cyclisation reaction in a non-halogenated solvent in the presence of a carboxylic acid. Preferably, R2 is H and R1 is OCH3. Trichloroacetic acid is preferablky used as .alpha.-chlorinated acid. The benzothiazepine obtained on cyclisation can be subjected to an alkylation reaction and/or an acylation reaction to obtain known pharmaceutical products, in particular diltiazem.
priorityDate 1996-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420053511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425613610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10131714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17929084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419742001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415856631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426110955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421425093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20307232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416154708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416150665

Total number of triples: 39.